Learn more

TEVA PHARM FINE CHEMICALS SRL

Overview
  • Total Patents
    87
About

TEVA PHARM FINE CHEMICALS SRL has a total of 87 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), China and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are UCHREZHDENIE ROSSIJSKOJ AKADEMII NAUK INST KHIM KOMI NAUCHNOGO TSENTRA URAL SKOGO OTDEL RAN, SYNTECO SPA and COSMOS PHARM CORP.

Patent filings per year

Chart showing TEVA PHARM FINE CHEMICALS SRLs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Organic fine chemistry
#2 Pharmaceuticals

Top inventors

# Name Total Patents
#1 Daverio Paola 47
#2 Mantovani Silvia 38
#3 Bianchi Stefano 34
#4 Castelli Eugenio 32
#5 Merli Valeriano 27
#6 Aronhime Judith 21
#7 Kovacsne-Mezei Adrienne 20
#8 Vailati Alessandra 16
#9 Riva Paolo 15
#10 Lo Monaco Giuseppe 10

Latest patents

Publication Filing date Title
EP1999100A1 Process for preparing memantine hydrochloride substantially free of impurities
EP1751085A1 Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
EP1889828A1 Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
CN101155775A Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
CN101102994A Polymorphs of memantine hydrochloride
MX2007007302A Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride.
US2006211772A1 Processes for the preparation of atomoxetine hydrochloride
CN1976894A Polymorphs of atomoxetine hydrochloride
EP1673335A2 Process for the preparation of atomoxetine hydrochloride
CN1950326A Process for the optical resolution and recycling of tomoxetine
ZA200605946B Levalbuterol hydrochloride polymorph B
EP1747189A1 Preparation of levalbuterol hydrochloride